ALLMedicine™ Invasive Lobular Carcinoma Center
Research & Reviews 615 results
https://doi.org/10.1016/j.clinimag.2021.01.039
Clinical Imaging; Durhan G, Poker A et. al.
Feb 14th, 2021 - The aim of this study was to evaluate the magnetic resonance imaging (MRI) findings of invasive breast cancer in different histopathological types (invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC) and mixed ductal-lobular carcinom...
https://doi.org/10.12659/AJCR.928012
The American Journal of Case Reports; Osmani AH, Tulbah AM et. al.
Feb 5th, 2021 - BACKGROUND Invasive lobular carcinoma is special subtype of breast cancer that has clinical behavior and morphology distinct from other breast cancer subtypes. It accounts for 5-15% of breast cancer. Overall, HER-2 gene amplification occurs at a s...
https://doi.org/10.1111/tbj.14161
The Breast Journal; Mukhtar RA, Brabham CE et. al.
Jan 24th, 2021 - Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast: Factors associated with false negatives.|2021|Mukhtar RA,Brabham CE,Guo R,Abel MK,Wong J,|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792208
Breast Cancer Research : BCR; McCart Reed AE, Kalinowski L et. al.
Jan 8th, 2021 - Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types, accounting for up to 15% of all breast cancer cases. ILCs are noted for their lack of E-cadherin function, which underpins their characteristic discohesive gro...
https://doi.org/10.1007/s10549-020-06056-9 10.1016/j.soc.2014.03.007 10.1148/rg.336125060 10.1245/s10434-012-2505-1 10.1001/jama.2017.11470 10.1001/jama.2011.90 10.1148/radiol.2020192534 10.4143/crt.2016.473 10.1245/s10434-014-3813-4 10.1007/s00330-015-3683-6 10.1245/s10434-017-5935-y 10.1186/s40644-019-0191-y 10.1016/j.ejso.2018.04.003 10.1245/s10434-014-3674-x 10.1016/j.crad.2017.12.014 10.1002/bjs.9663 10.1148/radiol.10100296 10.2214/ajr.05.0936 10.1136/jclinpath-2011-200151 10.1111/tbj.12042 10.1002/bjs.10791 10.2214/ajr.10.4889 10.1002/jmri.23706 10.1007/s00330-016-4235-4 10.1148/radiol.11103535 10.1007/s003300000370 10.1002/jmri.21802 10.1016/j.acra.2014.10.010 10.1148/radiol.11110639 10.1007/s13244-015-0404-2 10.1002/jmri.27246 10.4048/jbc.2015.18.1.63 10.1200/jco.2006.09.5448 10.1200/jco.2013.52.7515 10.1007/s10549-007-9528-5 10.1007/s00330-008-0863-7 10.2214/ajr.13.11355 10.2214/ajr.09.3122 10.1245/s10434-011-2200-7 10.1016/s1470-2045(14)70460-7 10.1177/0284185117723039 10.7326/0003-4819-118-3-199302010-00009 10.2214/ajr.12.9036 10.7863/ultra.33.10.1805 10.1200/jco.2005.03.111 10.1016/j.ejca.2010.02.015 10.1016/S1470-2045(13)70035-4
Breast Cancer Research and Treatment; Ha SM, Chang JM et. al.
Jan 3rd, 2021 - To investigate clinical and imaging features associated with a high nodal burden (≥ 3 metastatic lymph nodes [LNs]) and compare diagnostic performance of US and MRI in patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (I...
Clinicaltrials.gov 637 results
https://doi.org/10.1016/j.clinimag.2021.01.039
Clinical Imaging; Durhan G, Poker A et. al.
Feb 14th, 2021 - The aim of this study was to evaluate the magnetic resonance imaging (MRI) findings of invasive breast cancer in different histopathological types (invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC) and mixed ductal-lobular carcinom...
https://doi.org/10.12659/AJCR.928012
The American Journal of Case Reports; Osmani AH, Tulbah AM et. al.
Feb 5th, 2021 - BACKGROUND Invasive lobular carcinoma is special subtype of breast cancer that has clinical behavior and morphology distinct from other breast cancer subtypes. It accounts for 5-15% of breast cancer. Overall, HER-2 gene amplification occurs at a s...
https://doi.org/10.1111/tbj.14161
The Breast Journal; Mukhtar RA, Brabham CE et. al.
Jan 24th, 2021 - Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast: Factors associated with false negatives.|2021|Mukhtar RA,Brabham CE,Guo R,Abel MK,Wong J,|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792208
Breast Cancer Research : BCR; McCart Reed AE, Kalinowski L et. al.
Jan 8th, 2021 - Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types, accounting for up to 15% of all breast cancer cases. ILCs are noted for their lack of E-cadherin function, which underpins their characteristic discohesive gro...
https://doi.org/10.1007/s10549-020-06056-9 10.1016/j.soc.2014.03.007 10.1148/rg.336125060 10.1245/s10434-012-2505-1 10.1001/jama.2017.11470 10.1001/jama.2011.90 10.1148/radiol.2020192534 10.4143/crt.2016.473 10.1245/s10434-014-3813-4 10.1007/s00330-015-3683-6 10.1245/s10434-017-5935-y 10.1186/s40644-019-0191-y 10.1016/j.ejso.2018.04.003 10.1245/s10434-014-3674-x 10.1016/j.crad.2017.12.014 10.1002/bjs.9663 10.1148/radiol.10100296 10.2214/ajr.05.0936 10.1136/jclinpath-2011-200151 10.1111/tbj.12042 10.1002/bjs.10791 10.2214/ajr.10.4889 10.1002/jmri.23706 10.1007/s00330-016-4235-4 10.1148/radiol.11103535 10.1007/s003300000370 10.1002/jmri.21802 10.1016/j.acra.2014.10.010 10.1148/radiol.11110639 10.1007/s13244-015-0404-2 10.1002/jmri.27246 10.4048/jbc.2015.18.1.63 10.1200/jco.2006.09.5448 10.1200/jco.2013.52.7515 10.1007/s10549-007-9528-5 10.1007/s00330-008-0863-7 10.2214/ajr.13.11355 10.2214/ajr.09.3122 10.1245/s10434-011-2200-7 10.1016/s1470-2045(14)70460-7 10.1177/0284185117723039 10.7326/0003-4819-118-3-199302010-00009 10.2214/ajr.12.9036 10.7863/ultra.33.10.1805 10.1200/jco.2005.03.111 10.1016/j.ejca.2010.02.015 10.1016/S1470-2045(13)70035-4
Breast Cancer Research and Treatment; Ha SM, Chang JM et. al.
Jan 3rd, 2021 - To investigate clinical and imaging features associated with a high nodal burden (≥ 3 metastatic lymph nodes [LNs]) and compare diagnostic performance of US and MRI in patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (I...
News 7 results
https://www.staging.medscape.com/viewarticle/938558
Oct 5th, 2020 - NEW YORK (Reuters Health) - A test that looks at the activity of 70 genes in breast tumors can help identify women with invasive lobular carcinoma (ILC) at high-risk of cancer recurrence or progression after surgery who may benefit from additional...
https://www.medscape.com/viewarticle/938558
Oct 5th, 2020 - NEW YORK (Reuters Health) - A test that looks at the activity of 70 genes in breast tumors can help identify women with invasive lobular carcinoma (ILC) at high-risk of cancer recurrence or progression after surgery who may benefit from additional...
https://www.onclive.com/publications/oncology-live/2015/may-2015/distinct-strategies-needed-for-treating-lobular-breast-cancer
Apr 28th, 2015 - Jennifer Yuchen Shih, MD, MS Although patients with invasive lobular carcinoma (ILC) are typically treated with the same therapeutic strategies as those with infiltrating ductal malignancies, ILC is emerging as a molecularly complex and distinct t...
https://www.mdedge.com/hematology-oncology/article/80349/breast-cancer/guidelines-no-ink-tumor-adequate-surgical-margin/page/0/1
Feb 12th, 2014 - In additional findings, there was no evidence that wider margins beyond no ink on tumor are indicated in patients having more aggressive biological subtypes of breast cancer, invasive lobular carcinoma, or tumors with an extensive intraductal comp.
https://www.mdedge.com/internalmedicine/article/76950/hypertension/long-term-ccb-therapy-linked-higher-breast-cancer-risk
Mary Ann Moon
Aug 5th, 2013 - The long-term use of calcium-channel blockers is associated with a doubling of the risk of both invasive ductal carcinoma and invasive lobular carcinoma of the breast, according to a report published online Aug. 5 in JAMA Internal Medicine.
